INTU
54
2
ROST
60
3
RCL
74
5
LNC
28
3
LUV
45
3
PEP
33
4
AON
25
4
NEM
30
2
MDT
59
4
EXR
42
5
O
26
16
MTB
38
4
EQR
33
6
PM
49
8
KMI
69
8
CF
47
5
AMT
30
2
CAG
34
3
ICE
53
5
LRCX
56
4
INTU
54
2
ROST
60
3
RCL
74
5
LNC
28
3
LUV
45
3
PEP
33
4
AON
25
4
NEM
30
2
MDT
59
4
EXR
42
5
O
26
16
MTB
38
4
EQR
33
6
PM
49
8
KMI
69
8
CF
47
5
AMT
30
2
CAG
34
3
ICE
53
5
LRCX
56
4
Financhill
Back

Aptevo Therapeutics Vs. Keros Therapeutics Industry Stock Comparison

Sell
27

APVO
Aptevo Therapeutics

Last Price:
$4.36
Seasonality Move:
-31.63%
Sell
4

KROS
Keros Therapeutics

Last Price:
$17.04
Seasonality Move:
16.43%
Sell
27
Aptevo Therapeutics (APVO) is a Sell

Is Aptevo Therapeutics a Buy, Sell or Hold?

  • The current Aptevo Therapeutics [APVO] share price is $4.36. The Score for APVO is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • APVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
4
Keros Therapeutics (KROS) is a Sell

Is Keros Therapeutics a Buy, Sell or Hold?

  • The current Keros Therapeutics [KROS] share price is $17.03. The Score for KROS is 4, which is 92% below its historic median score of 50, and infers higher risk than normal.
  • KROS is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

APVO Stock Price Chart

What is Aptevo Therapeutics's stock price today?

  • The Aptevo Therapeutics share price today is $4.36
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APVO is experiencing slight selling pressure.

KROS Stock Price Chart

What is Keros Therapeutics's stock price today?

  • The Keros Therapeutics share price today is $17.03
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight selling pressure.

APVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.47 Sell
Relative Strength Index (14 RSI): 35.08 Sell
Chaikin Money Flow: -43529 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.66 - 11.16) Sell
Bollinger Bands (100): (6.54 - 13.42) Sell

KROS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -11.49 Sell
Relative Strength Index (14 RSI): 22.6 Sell
Chaikin Money Flow: -285503 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.79 - 67.83) Sell
Bollinger Bands (100): (41.67 - 65.17) Sell

APVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.12 Sell
20-day SMA: 8.24 Sell
50-day SMA: 8.71 Sell
200-day SMA: 32.53 Sell
8-day EMA: 5.29 Sell
20-day EMA: 7.09 Sell
50-day EMA: 8.69 Sell
200-day EMA: 168.98 Sell

KROS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.3 Sell
20-day SMA: 46.77 Sell
50-day SMA: 55 Sell
200-day SMA: 53.85 Sell
8-day EMA: 25.85 Sell
20-day EMA: 40.07 Sell
50-day EMA: 49.85 Sell
200-day EMA: 51.91 Sell

Aptevo Therapeutics Earnings Growth & APVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $17.55 per share, a decrease next quarter of $0.00 per share, an increase this year of $3,536.34 per share, and an increase next year of $71.15 per share.

Keros Therapeutics Earnings Growth & KROS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.03 per share, and an increase next year of $0.20 per share.

Aptevo Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Keros Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):